NxStage Medical Stock Hits New 52-Week Low (NXTM)

NEW YORK ( TheStreet) -- NxStage Medical Incorporated (Nasdaq: NXTM) hit a new 52-week low Thursday as it is currently trading at $16.24, below its previous 52-week low of $16.29 with 93,900 shares traded as of 10:20 a.m. ET. Average volume has been 437,400 shares over the past 30 days.

NxStage Medical has a market cap of $993.1 million and is part of the health care sector and health services industry. Shares are down 5.8% year to date as of the close of trading on Wednesday.

NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures.

TheStreet Ratings rates NxStage Medical as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. You can view the full NxStage Medical Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

null
Markets Stocks

More from Markets

Snap Shares Plunge After Cowen Cuts Price Target

Snap Shares Plunge After Cowen Cuts Price Target
Katherine Ross
FANG Stocks Get Swept Up in Broader Market Selloff

FANG Stocks Get Swept Up in Broader Market Selloff
Katherine Ross
Dow Tumbles as Trump Ratchets Up China Trade Fight

Dow Tumbles as Trump Ratchets Up China Trade Fight
TheStreet Staff
Sarepta Shares Skyrocket on Early Results for DMD Gene Therapy

Sarepta Shares Skyrocket on Early Results for DMD Gene Therapy
Bill Meagher
Steel and Aluminum Stocks Suffer Amidst Trade War Woes

Steel and Aluminum Stocks Suffer Amidst Trade War Woes
Katherine Ross